Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Catarina Duarte

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Rheumatology (Oxford, England)|February 1, 2021
Happiness, quality of life and their determinants among people with systemic sclerosis: a structural equation modelling approachTânia Santiago, Eduardo Santos, Ana Catarina Duarte, et al.
Arthritis Research & Therapy|September 22, 2023
Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomesFilipa Oliveira Ramos, Ana Maria Rodrigues, Ana Teresa Melo, et al.
RMD Open|November 25, 2021
Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseasesFilipa Oliveira Ramos, Ana Rodrigues, Fernando Magalhaes Martins, et al.
Clinical Rheumatology|January 16, 2026
Safety and effectiveness of rituximab therapy in Sjögren's disease: a PORTRESS - the Portuguese registry of Sjögren's disease-based studyCarla Campinho Ferreira, Matilde Bandeira, Roberto Pereira da Costa, et al.
The Journal of Rheumatology|August 3, 2019
Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese RegisterElsa Vieira-Sousa, Mónica Eusébio, Pedro Ávila-Ribeiro, et al.
Acta Reumatologica Portuguesa|June 28, 2019
Tocilizumab and rituximab have similar effectiveness and are both superior to a second tumour necrosis factor inhibitor in rheumatoid arthritis patients who discontinued a first TNF inhibitorDaniela Santos-Faria, José Tavares-Costa, Mónica Eusébio, et al.
ARP Rheumatology|May 28, 2022
Clinical features and outcome of 1054 patients with Systemic Sclerosis: analysis of Reuma.pt/SSc registryRaquel Freitas, Patrícia Martins, Eduardo Dourado, et al.
Clinical Rheumatology|November 20, 2021
Gender differences in clinical features and outcomes of a Portuguese systemic sclerosis cohortRaquel Freitas, Patrícia Martins, Eduardo Dourado, et al.
Seminars in Arthritis and Rheumatism|September 11, 2023
The phenotype of mixed connective tissue disease patients having associated interstitial lung diseaseGonçalo Boleto, Silje Reiseter, Anna-Maria Hoffmann-Vold, et al.
Rheumatology (Oxford, England)|February 6, 2024
Predictors of myositis in systemic sclerosisEduardo Dourado, Carolina Mazeda, Raquel Freitas, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Rheumatology (Oxford, England)|February 1, 2021
Happiness, quality of life and their determinants among people with systemic sclerosis: a structural equation modelling approachTânia Santiago, Eduardo Santos, Ana Catarina Duarte, et al.
Arthritis Research & Therapy|September 22, 2023
Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomesFilipa Oliveira Ramos, Ana Maria Rodrigues, Ana Teresa Melo, et al.
RMD Open|November 25, 2021
Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseasesFilipa Oliveira Ramos, Ana Rodrigues, Fernando Magalhaes Martins, et al.
Clinical Rheumatology|January 16, 2026
Safety and effectiveness of rituximab therapy in Sjögren's disease: a PORTRESS - the Portuguese registry of Sjögren's disease-based studyCarla Campinho Ferreira, Matilde Bandeira, Roberto Pereira da Costa, et al.
The Journal of Rheumatology|August 3, 2019
Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese RegisterElsa Vieira-Sousa, Mónica Eusébio, Pedro Ávila-Ribeiro, et al.
Acta Reumatologica Portuguesa|June 28, 2019
Tocilizumab and rituximab have similar effectiveness and are both superior to a second tumour necrosis factor inhibitor in rheumatoid arthritis patients who discontinued a first TNF inhibitorDaniela Santos-Faria, José Tavares-Costa, Mónica Eusébio, et al.
ARP Rheumatology|May 28, 2022
Clinical features and outcome of 1054 patients with Systemic Sclerosis: analysis of Reuma.pt/SSc registryRaquel Freitas, Patrícia Martins, Eduardo Dourado, et al.
Clinical Rheumatology|November 20, 2021
Gender differences in clinical features and outcomes of a Portuguese systemic sclerosis cohortRaquel Freitas, Patrícia Martins, Eduardo Dourado, et al.
Seminars in Arthritis and Rheumatism|September 11, 2023
The phenotype of mixed connective tissue disease patients having associated interstitial lung diseaseGonçalo Boleto, Silje Reiseter, Anna-Maria Hoffmann-Vold, et al.
Rheumatology (Oxford, England)|February 6, 2024
Predictors of myositis in systemic sclerosisEduardo Dourado, Carolina Mazeda, Raquel Freitas, et al.
Pageof 6